The healthcare industry is experiencing the most dramatic transformation in decades, driven by digital health innovation that’s reshaping how we diagnose, treat, and prevent disease. From AI-powered diagnostics to prescription digital therapeutics, 2025 has marked a pivotal year where digital health technologies have moved from experimental concepts to mainstream medical practice, fundamentally changing the healthcare landscape for providers and patients alike.
The Current State of Digital Health Innovation: A Market on Fire
The numbers tell a compelling story of explosive growth. The global digital health market is expected to reach USD 573.53 billion by 2030, up from USD 199.14 billion in 2025, at a CAGR of 23.6% during the forecast period. Market growth is mainly driven by technological improvements, increasing demand for remote care, chronic disease management, cost reduction efforts, regulatory backing, and greater patient involvement.
This remarkable expansion is fueled by several converging factors that have aligned perfectly in 2025-2026. The U.S. healthcare system is entering a rare turning point — not because digital health is new, but because the forces shaping it have finally aligned with urgency. The U.S. digital health market is now evolving faster than at any point in the past decade, driven by regulatory clarity, investment shifts, and rising expectations.
Health systems across the globe are under unprecedented strain. Workforce shortages, clinician burnout, cost inflation, and rising patient demand have transformed digital transformation from a “nice to have” into a strategic imperative. This pressure has created an environment where digital health innovation isn’t just welcomed—it’s essential for survival.
Artificial Intelligence: The Powerhouse Behind Digital Health Innovation
Perhaps no technology exemplifies digital health innovation more than artificial intelligence in healthcare. The FDA’s approval data reveals the explosive growth in this sector. 2025 marked a breakthrough year for AI/ML medical devices, with 295 FDA clearances spanning diagnostic tools to therapeutic software. This surge—from both industry leaders and startups—demonstrates AI’s central role in modern healthcare. The data is clear: intelligent medicine is here, reshaping patient care with unprecedented speed and scale.
The regulatory landscape has evolved rapidly to accommodate this growth. In 2025, the Centers for Medicare & Medicaid Services introduced new codes to facilitate Medicare reimbursement of digital mental health treatment devices (i.e., digital therapeutics) provided “incident to” care and has signaled it may extend this approach to other software-based solutions. Growing use of AI-enabled diagnostic tests in the private sector has prompted the creation of the first Category I CPT codes for inclusion in the 2026 Medicare Physician Fee Schedule.
The scope of AI applications continues to expand dramatically. By mid-2025 the FDA had added 115 radiology AI algorithms to its approved list (approximately 873 total) – making medical imaging the single largest AI target among specialties. Leading vendors include GE Healthcare (96 cleared tools), Siemens Healthineers (80), Philips (42), Canon (35), United Imaging (32), Aidoc (30) and many startups, reflecting intense industry focus.
A significant milestone was reached in February 2025 when Aidoc’s CARE1™ foundation model received FDA clearance — the first foundation-model-powered clinical AI to do so. This breakthrough represents the beginning of a new era where large language models and generative AI systems are being integrated into clinical workflows, marking a fundamental shift in digital health innovation.
AI-Powered Diagnostics Transform Patient Care
The practical applications of AI in healthcare are already delivering measurable results. These codes will help providers analyze coronary arterial plaque to prevent blockages, assess heart disease risk by analyzing fat around blood vessels, determine burn severity via imaging, and identify heart problems using acoustic and ECG signals. This represents a shift from reactive to preventive care, where AI helps identify problems before they become critical.
The adoption rates vary significantly by region, but the trend is unmistakable. Survey data show rapidly growing clinical use. A 2024 European radiologist survey found 48% of respondents were actively using AI tools (up from 20% in 2018), with another 25% planning to use them. By contrast, a U.S. report estimated only ~2% of practices use AI today, indicating regional variation.
Digital Therapeutics: Prescription Apps Are Now Reality
One of the most exciting developments in digital health innovation is the emergence of prescription digital therapeutics (PDTs)—evidence-based software applications that can treat medical conditions and are prescribed by healthcare providers just like traditional medications.
In November 2024, the Centers for Medicare and Medicaid Services (CMS) approved three new reimbursement codes for these digital interventions, which typically collect data on mood, sleep, substance use, or other behaviors and offer cognitive-behavioral therapy to the user. While the new CMS codes only cover Medicare patients for now, early adopters of digital therapeutics are optimistic that their efforts will build a case for commercial insurance companies to start reimbursing providers for these treatments.
The regulatory approvals have been accelerating rapidly. As of early 2026, 12 FDA-cleared or authorized prescription digital therapeutics are available in the United States. Notable examples include:
- Rejoyn: FDA cleared April 2024, adults 22+. The first prescription digital therapeutic ever authorized for Major Depressive Disorder.
- DaylightRx: FDA cleared September 2024, adults 22+. The first PDT cleared for Generalized Anxiety Disorder (GAD).
- MamaLift Plus: FDA cleared as the first prescription digital therapeutic for the symptomatic treatment of mild to moderate postpartum depression (PPD) among patients aged 22 years and older.
The market response has been encouraging. In September 2025, Cigna Healthcare, a large commercial insurance company, announced that the health plan will start covering FDA-approved digital therapeutics. This signals a broader trend toward mainstream adoption and insurance coverage for these innovative treatments.
However, challenges remain. Every FDA-approved app I have seen needs to be used under the direction of a physician, and many psychiatrists are unsure whether to prescribe these, as they are unsure if the apps actually work well enough to make a difference for the patients they treat. He noted that digital therapeutics are FDA-authorized as medical devices, and the evidence required by the FDA for authorization of these devices is often less rigorous than the evidence required for medication approval.
Wearable Health Technology: The Consumer Revolution in Digital Health Innovation
Wearable health devices represent perhaps the most visible aspect of digital health innovation, with consumers increasingly adopting sophisticated monitoring devices that provide continuous health insights.
The market growth is staggering. The global fitness tracker market size is calculated at USD 71.93 billion in 2025, grew to USD 84.91 billion in 2026, and is projected to reach around USD 377.77 billion by 2035. The market is expanding at a CAGR of 18.04% between 2026 and 2035.
The broader wearable technology market is equally impressive. The global wearable technology market size was valued at USD 86.78 billion in 2025 and is projected to grow from USD 96.44 billion in 2026 to USD 231.43 billion by 2034, exhibiting a CAGR of 11.60% during the forecast period.
What’s particularly interesting is the evolution beyond simple fitness tracking. While the range of form factors continues to grow, we saw movement from novelty to real adoption this year. Rings led a lot of the heavy lifting: Oura’s $900M raise at a nearly $11B valuation became the largest digital health deal on record since we began tracking funding in 2011, as the company sold more rings in just over a single year than the prior 11 years combined.
Advanced Health Monitoring Capabilities
Modern wearable devices are becoming increasingly sophisticated medical monitoring tools. The device costs $59.99 and is available in the U.S. market. The tracker can provide personalized sleep coaching, contains a blood oxygen sensor, and detects snoring. In November 2024, researchers from Brigham and Women’s Hospital evaluated the data collected from a fitness tracker to detect mood episodes in people with bipolar disorders. They found that fitness trackers could accurately detect up to 89.1% of mania and 80.1% of depression.
The medical applications continue to expand. The global wearable medical devices market size was valued at USD 103.04 billion in 2025 and is projected to grow from USD 117.41 billion in 2026 to USD 505.28 billion by 2034, exhibiting a CAGR of 20% during the forecast period.
Investment and Funding Trends: Capital Flows into Digital Health Innovation
The financial backing for digital health innovation has shown remarkable resilience and focus in 2025-2026, with investors becoming more selective but also more committed to proven solutions.
Digital health startups pocketed $4 billion in venture capital funding in the first quarter of 2026, $1 billion higher than the same quarter last year and marking the strongest first quarter since the pandemic peak.
The funding landscape has become increasingly concentrated among successful companies. While overall deal counts fell to a five-year low in 2025, capital concentration increased. Mega-deals (rounds of $100 million or more) remained a defining feature of the funding landscape, accounting for nearly 40% of total digital health investment.
Interestingly, healthcare providers are no longer passive buyers but active partners in innovation. In 2025, health systems accounted for 18% of more than 3,150 digital health partnerships announced globally. These partnerships signal a deeper form of engagement—one where hospitals and health systems actively shape product roadmaps, co-develop solutions, and commit to long-term adoption.
The focus has shifted toward solutions that address immediate operational challenges. In response, Health Management Solutions overtook Research Solutions as the most funded digital health cluster of the year. This shift mirrors what Galen Growth has observed across multiple cycles: when healthcare systems are under pressure, investment flows toward tools that improve efficiency, coordination, and decision-making.
Regulatory Evolution: Enabling Innovation While Ensuring Safety
The regulatory environment for digital health innovation has evolved rapidly to keep pace with technological advancement while maintaining safety standards.
On December 22, 2025, HHS, through the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (“ASTP/ONC”), released the HTI-5 Proposed Rule. Among other proposals, HTI-5 proposes withdrawing or revising more than half of the existing technical and interoperability requirements for certified EHR technology as part of the Health IT Certification Program and updating ASTP/ONC’s information blocking regulations.
This regulatory evolution aims to accelerate innovation. The proposal aims to streamline certification by reducing prescriptive EHR functionality requirements in favor of API-focused certification, with the goal of enabling greater interoperability, improving patient access to electronic health information, and unlocking innovation by third-party AI-enabled apps.
CMS has also been proactive in supporting digital health adoption. Starting July 2026, the CMS Innovation Center will roll out its ACCESS Model (“Advancing Chronic Care with Effective, Scalable Solutions”), a voluntary, ten-year payment model that incentivizes use of technology to manage chronic conditions. Under the ACCESS Model, Medicare Part B providers will be rewarded with recurring payments for using technology-enabled services to improve patient outcomes and coordinate care.
Conclusion: The Future of Digital Health Innovation
The evidence is overwhelming: digital health innovation has moved from a promising concept to a fundamental pillar of modern healthcare. The convergence of AI-powered diagnostics, prescription digital therapeutics, advanced wearables, and supportive regulatory frameworks has created an ecosystem where technology truly enhances patient care and provider efficiency.
Digital health is entering a new phase in 2025, as stakeholders refine evidence standards, reimbursement pathways, and business models. This research brief highlights global policy shifts, U.S. billing trends, AI-enabled innovation, and the strategies shaping sustainable adoption.
Key takeaways from the current state of digital health innovation include:
- AI is becoming mainstream: With nearly 300 FDA approvals in 2025 alone, AI-enabled medical devices are transitioning from experimental to essential tools
- Digital therapeutics offer new treatment paradigms: Prescription apps are creating entirely new categories of evidence-based treatments
- Wearables are evolving into medical devices: Consumer health trackers are becoming sophisticated monitoring tools with clinical applications
- Investment capital is consolidating around proven solutions: Mega-deals and strategic partnerships signal market maturation
- Regulatory frameworks are adapting rapidly: New billing codes, streamlined approvals, and innovation-friendly policies are accelerating adoption
Digital health enters 2026 with those same dynamics to contend with—enabling the potential for both faster lift and sharper drops. However, the foundation built in 2025 suggests that digital health innovation is not just a temporary trend but a permanent transformation of healthcare delivery.
Ready to be part of the digital health revolution? Whether you’re a healthcare provider looking to integrate digital solutions, an investor seeking opportunities in this booming market, or a patient interested in accessing cutting-edge digital health tools, now is the time to engage with this transformative industry. The future of healthcare is being written today through digital health innovation—and the opportunities for improving patient outcomes while reducing costs have never been greater. Connect with digital health leaders, explore FDA-approved solutions, and discover how these technologies can enhance your healthcare journey or practice. The digital health revolution isn’t coming—it’s here, and it’s changing lives every day.
Leave a Comment